The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic ...

Medtronic (NYSE: MDT) announced today that it received new labeling approval from the FDA for its Endurant stent graft system.

LeMaitre Vascular (NASDAQ: LMAT) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ...

Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic ...

Medtronic announced that the FDA has approved new labeling for the company’s Endurant stent graft system for use in the t ...

Aortic endografts are minimally invasive medical devices used in the treatment of aortic aneurysms, particularly abdominal ...

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, ...

Clearance expands Company's competitive advantage of clinically proven, minimally invasive technologies to treat debilitating SI joint conditions from multiple surgical approaches~~SImmetry+'s New 3D ...

Results published in Oxford Academic’s Military Medicine Journal -- After up to 18 months of follow-up patients were observed to have zero ...

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than ...

Humacyte faces high volatility after Symvess approval positive trauma data but repeated dilutive fundraisings and safety concerns. Find out why HUMA is a Buy.

Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or ...